Scandinavian Biopharma expand their portfolio with Coagadex® - the first and only tailormade treatment for the rare bleeding disorder ‘factor X deficiency’
Scandinavian Biopharma has entered into a distribution agreement with Bio Products Laboratory Limited (BPL), a leading manufacturer of plasma-derived protein therapies, for their unique factor X deficiency product Coagadex®.